Bull case
The bull case requires both strong earnings delivery and the market pricing AMRZ more generously than it does today.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where AMRZ stock could go
The bull case requires both strong earnings delivery and the market pricing AMRZ more generously than it does today.
The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Amrize is a building materials company that manufactures and distributes construction products across North America. It generates revenue primarily through sales of cement, aggregates, and ready-mix concrete — with cement typically representing the largest segment at around 40-50% of total revenue. The company benefits from strategic plant locations near key markets — creating a logistics cost advantage — and operates at scale in a capital-intensive industry with high barriers to entry.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.78/$1.03 | -24.3% | $3.2B/$3.4B | -5.0% |
| Q4 2025 | $1.06/$1.02 | +3.9% | $3.7B/$3.5B | +5.4% |
| Q1 2026 | $0.54/$0.65 | -16.4% | $2.8B/$2.9B | -2.8% |
AMRZ beat EPS estimates in 1 of 3 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $71 — implies +32.2% from today's price.
| Metric | AMRZ | S&P 500 | Basic Materials | 5Y Avg AMRZ |
|---|---|---|---|---|
| Forward PE | 19.0x | 19.1x | 15.2x+25% | — |
| Trailing PE | 24.9x | 25.1x | 22.3x+12% | 25.3x |
| PEG Ratio | — | 1.72x | 1.17x | — |
| EV/EBITDA | 12.1x | 15.2x-20% | 11.0x+11% | 12.0x |
| Price/FCF | 21.3x | 21.1x | 25.6x-17% | 21.1x |
| Price/Sales | 2.6x | 3.1x-18% | 1.9x+35% | 2.5x |
| Dividend Yield | — | 1.87% | 1.32% | — |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolAMRZ generates $1.4B in free cash flow at a 12.0% margin.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~2.8 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Amrize faces significant legal and regulatory risk, with compliance and potential regulatory changes cited as a primary concern. Failure to meet regulatory requirements could result in fines, operational restrictions, or costly litigation, directly impacting profitability.
The company’s ability to maintain cement plant uptime and execute capital expenditure programs is critical. Delays or failures in plant operations, coupled with challenges integrating future mergers and acquisitions, could erode margins and strain cash flow.
A slowdown in the construction industry could reduce demand for Amrize’s products. Although lower interest rates and a positive growth outlook mitigate this risk, a significant downturn would still negatively affect revenue.
Amrize competes with large players such as CRH, Vulcan Materials, and Cemex. Intense competition could pressure pricing, erode market share, and squeeze operating margins.
Past cement plant outages have impacted the company, and future outages could disrupt supply chains and production. Effective maintenance and contingency planning are essential to avoid revenue loss.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Backlog from data centers, energy, and infrastructure projects is expected to drive demand for Amrize's cement, aggregates, and roofing materials. The company benefits from multi‑year contracts in these sectors.
Amrize offers a broad portfolio from cement and aggregates to roofing and wall systems, serving infrastructure, commercial, and residential construction markets. This product diversity supports stable demand across market cycles.
Investments in Ste. Genevieve, Malarkey in Indiana, and upgrades at St. Constant, Exshaw, and Midlothian aim to add low‑cost capacity. These projects are designed to increase production efficiency and support growth.
The new capacity is expected to be utilized at higher rates, which should lift EBITDA margins. Improved operational efficiency is a key catalyst for profitability.
Amrize projects 4‑6% revenue growth for 2026, reflecting the demand momentum and capacity expansion. This growth trajectory underpins the bullish thesis.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
AMR AMRZ Amrize Ltd | $30.3B | 19.0x | — | 10.3% | Buy | +23.9% |
VMC VMC Vulcan Materials Company | $37.8B | 31.7x | +5.0% | 13.9% | Buy | +12.2% |
MLM MLM Martin Marietta Materials, Inc. | $36.6B | 31.0x | +4.8% | 38.7% | Buy | +14.7% |
EXP EXP Eagle Materials Inc. | $6.8B | 16.2x | +2.6% | 19.4% | Buy | +6.9% |
CRH CRH CRH plc | $75.2B | 18.9x | -1.8% | 9.2% | Buy | +20.5% |
FYB FYBR Frontier Communications Parent, Inc. | $9.6B | — | +0.4% | -6.2% | Buy | -10.8% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
AMRZ does not currently return meaningful capital to shareholders.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw |
|---|---|---|
| 2026 | $0.44 | — |
Common questions answered from live analyst data and company financials.
Amrize Ltd (AMRZ) is rated Buy by Wall Street analysts as of 2026. Of 7 analysts covering the stock, 5 rate it Buy or Strong Buy, 2 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $66, implying +23.9% from the current price of $53.
The Wall Street consensus price target for AMRZ is $66 based on 7 analyst estimates. The high-end target is $75 (+40.5% from today), and the low-end target is $58 (+8.7%).
AMRZ trades at 19.0x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals significantly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for AMRZ in 2026 are: (1) Legal & Regulatory — Amrize faces significant legal and regulatory risk, with compliance and potential regulatory changes cited as a primary concern. (2) Execution & Integration Risks — The company’s ability to maintain cement plant uptime and execute capital expenditure programs is critical. (3) Construction Market Fluctuations — A slowdown in the construction industry could reduce demand for Amrize’s products. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Amrize Ltd is expected to report its next earnings on approximately 2026-05-19. Consensus expects EPS of $-0.12 and revenue of $2.1B. Over recent quarters, AMRZ has beaten EPS estimates 33% of the time.
Amrize Ltd (AMRZ) generated $1.4B in free cash flow over the trailing twelve months — a free cash flow margin of 12.0%. AMRZ returns capital to shareholders through and share repurchases ($0 TTM).